Applied DNA Sciences Inc (APDN) - Total Liabilities
Based on the latest financial reports, Applied DNA Sciences Inc (APDN) has total liabilities worth $2.95 Million USD as of June 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.
Applied DNA Sciences Inc - Total Liabilities Trend (1997–2025)
This chart illustrates how Applied DNA Sciences Inc's total liabilities have evolved over time, based on quarterly financial data. Explore Applied DNA Sciences Inc long-term investment allocation to see how much of total assets are deployed in long-term investments.
Applied DNA Sciences Inc Competitors by Total Liabilities
The table below lists competitors of Applied DNA Sciences Inc ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Metalex Ventures Ltd.
V:MTX
|
Canada | CA$2.65 Million |
|
Zephyr Minerals Ltd
V:ZFR
|
Canada | CA$250.96K |
|
Collplant Biotechnologies Ltd
NASDAQ:CLGN
|
USA | $4.78 Million |
|
Oriental Trimex Limited
NSE:ORIENTALTL
|
India | Rs381.79 Million |
|
Prima Alloy Steel Universal
JK:PRAS
|
Indonesia | Rp1.19 Trillion |
|
Boku Inc
LSE:BOKU
|
UK | GBX347.92 Million |
|
SILVER HAMMER MINING CORP
F:7BW0
|
Germany | €264.48K |
|
Kuniko Ltd
AU:KNI
|
Australia | AU$1.95 Million |
Liability Composition Analysis (1997–2025)
This chart breaks down Applied DNA Sciences Inc's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the complete balance sheet picture, see Applied DNA Sciences Inc (APDN) total assets.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 2.76 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.41 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.30 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Applied DNA Sciences Inc's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Applied DNA Sciences Inc (1997–2025)
The table below shows the annual total liabilities of Applied DNA Sciences Inc from 1997 to 2025.
| Year | Total Liabilities | Change |
|---|---|---|
| 2025-09-30 | $2.50 Million | -34.68% |
| 2024-09-30 | $3.82 Million | -56.48% |
| 2023-09-30 | $8.78 Million | -6.17% |
| 2022-09-30 | $9.36 Million | +183.19% |
| 2021-09-30 | $3.30 Million | -41.34% |
| 2020-09-30 | $5.63 Million | +27.61% |
| 2019-09-30 | $4.41 Million | -9.55% |
| 2018-09-30 | $4.88 Million | +276.52% |
| 2017-09-30 | $1.30 Million | -75.08% |
| 2016-09-30 | $5.20 Million | +74.08% |
| 2015-09-30 | $2.99 Million | -39.94% |
| 2014-09-30 | $4.97 Million | +32.34% |
| 2013-09-30 | $3.76 Million | +534.94% |
| 2012-09-30 | $592.01K | -86.84% |
| 2011-09-30 | $4.50 Million | +49.40% |
| 2010-09-30 | $3.01 Million | -7.45% |
| 2009-09-30 | $3.25 Million | -79.52% |
| 2008-09-30 | $15.88 Million | +10.64% |
| 2007-09-30 | $14.36 Million | +0.65% |
| 2006-09-30 | $14.26 Million | +449.45% |
| 2005-09-30 | $2.60 Million | -45.79% |
| 2004-09-30 | $4.79 Million | +510.12% |
| 2003-09-30 | $784.79K | +81394.08% |
| 2001-09-30 | $963.00 | -24.94% |
| 2000-09-30 | $1.28K | +33.23% |
| 1999-09-30 | $963.00 | -81.59% |
| 1998-09-30 | $5.23K | +43.35% |
| 1997-09-30 | $3.65K | -- |
About Applied DNA Sciences Inc
Applied DNA Sciences, Inc., a biotechnology company, develops and commercializes technologies to produce and detect deoxyribonucleic acid (DNA) in the Americas, Europe, Asia, and internationally. It operates through three segments: Therapeutic DNA Production Services; MDx Testing Services; and DNA Tagging and Security Products and Services. The Therapeutic DNA Production Services segment develops… Read more